ID Biomedical & Xillix Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ID Biomedical & Xillix Technologies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Cressman who wrote (10)	12/4/1997 2:38:00 PM
From: F. Jay Abella, III	Read Replies (1) of 16

Phil: I follow IDBEF for Westergaard Online (www.westergaard.com/Med/biotech.html). I was very bullish on the company too, even in the face of the slide in Canadian markets. However, speaking as someone who has actually tried to develop a gp120 loop inhibiting AIDS vaccine, I can tell you that this one is most likely a loser. It disturbs me that IDBEF will spend scarce resources on its development. I continue to see promise in the diagnostics and other vaccine areas the company is pursuing. A distribution agreement or other news from the Lehman initiative will really drive the stock short term. FJ Abella

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next